氨溴索联合亚胺培南治疗重症肺炎的临床效果

打开文本图片集

【摘要】目的：分析氨溴索联合亚胺培南治疗重症肺炎的临床效果。方法：选取我院2019年6月—2022年6月的82例重症肺炎患者，随机将其分成为两组。对照组采取亚胺培南，观察组联合采取氨溴索。结果：治疗前，两组的血清SAA、PCT、WBC计数、IL-1β和CRP水平无明显差异（P>0.05），治疗后，两组的血清SAA、PCT、WBC计数、IL-1β和CRP水平均明显降低（P0.05），治疗后，两组的PaO2、PaO2 /FiO2水平均明显升高（P

【关键词】氨溴索；亚胺培南；重症肺炎

Clinical effect of ambroxol combined with imipenem in the treatment of severe pneumonia

DUAN Baoxia

First People’s Hospital of Tianshui， Tianshui， Gansu 741000， China

【Abstract】Objective： To analyze the clinical effect of ambroxol combined with imipenem in the treatment of severe pneumonia. Methods： A total of 82 patients with severe pneumonia in our hospital from June 2019 to June 2022 were selected and randomly divided into two groups. The control group took imipenem， and the observation group took ambroxol. Results： Before treatment， there was no significant difference in serum SAA， PCT， WBC count， IL-1β and CRP levels between the two groups （P>0.05）. After treatment， serum SAA， PCT， WBC count， IL-1β and CRP levels in both groups were significantly decreased （P0.05）. After treatment， the levels of PaO2 and PaO2 /FiO2 in the two groups were significantly increased （P

【Key Words】Ambroxol； Imipenem； Severe pneumonia

重症肺炎指的是患者的病灶部位累及机体内多个肺叶，导致肺实质发生严重感染的一种临床急重症，病原菌主要为细菌、支原体、真菌和病毒等。（剩余4326字）